These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 26230097

  • 21. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
    Castle PE, Stoler MH, Wright TC, Sharma A, Wright TL, Behrens CM.
    Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
    [Abstract] [Full Text] [Related]

  • 22. p16/Ki67 dual staining improves the detection specificity of high-grade cervical lesions.
    Zhang R, Ge X, You K, Guo Y, Guo H, Wang Y, Geng L.
    J Obstet Gynaecol Res; 2018 Nov; 44(11):2077-2084. PubMed ID: 30094887
    [Abstract] [Full Text] [Related]

  • 23. p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.
    Zhang G, Yang B, Abdul-Karim FW.
    Int J Gynecol Pathol; 2015 Mar; 34(2):180-6. PubMed ID: 25675189
    [Abstract] [Full Text] [Related]

  • 24. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 25. Immunocytochemical colocalization of P16(INK4a) and Ki-67 predicts CIN2/3 and AIS/adenocarcinoma.
    Singh M, Mockler D, Akalin A, Burke S, Shroyer A, Shroyer KR.
    Cancer Cytopathol; 2012 Feb 25; 120(1):26-34. PubMed ID: 22162342
    [Abstract] [Full Text] [Related]

  • 26. High-risk human papillomavirus DNA test and p16(INK4a) in the triage of LSIL: a prospective diagnostic study.
    Tsoumpou I, Valasoulis G, Founta C, Kyrgiou M, Nasioutziki M, Daponte A, Koliopoulos G, Malamou-Mitsi V, Karakitsos P, Paraskevaidis E.
    Gynecol Oncol; 2011 Apr 25; 121(1):49-53. PubMed ID: 21194734
    [Abstract] [Full Text] [Related]

  • 27. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
    Koo YJ, Hahn HS, Lee IH, Lim KT, Lee KH, Kim HS, Kim TJ, Chun YK, Kim HS, Hong SR.
    Virchows Arch; 2013 Nov 25; 463(5):689-96. PubMed ID: 24081504
    [Abstract] [Full Text] [Related]

  • 28. [Sorting role of p16(INK4a)/Ki-67 double immunostaining in the cervical cytology specimens of ASCUS and LSIL cases].
    Yu J, Zhu HT, Zhao JJ, Su JZ, Xia YD.
    Zhonghua Bing Li Xue Za Zhi; 2017 May 08; 46(5):323-326. PubMed ID: 28468038
    [Abstract] [Full Text] [Related]

  • 29. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
    Pan QJ, Hu SY, Guo HQ, Zhang WH, Zhang X, Chen W, Cao J, Jiang Y, Zhao FH, Qiao YL.
    Gynecol Oncol; 2014 May 08; 133(2):172-9. PubMed ID: 24631450
    [Abstract] [Full Text] [Related]

  • 30. Combined use of cytology, p16 immunostaining and genotyping for triage of women positive for high-risk human papillomavirus at primary screening.
    Cuzick J, Adcock R, Carozzi F, Gillio-Tos A, De Marco L, Del Mistro A, Frayle H, Girlando S, Sani C, Confortini M, Zorzi M, Giorgi-Rossi P, Rizzolo R, Ronco G, New Technologies for Cervical Cancer Screening Working Group.
    Int J Cancer; 2020 Oct 01; 147(7):1864-1873. PubMed ID: 32170961
    [Abstract] [Full Text] [Related]

  • 31. Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study.
    White CM, Bakhiet S, Bates M, Ruttle C, Pilkington LJ, Keegan H, O'Toole SA, Sharp L, O'Kelly R, Tewari P, Flannelly G, Martin CM, O'Leary JJ, CERVIVA consortium.
    Cancer Epidemiol; 2020 Oct 01; 68():101793. PubMed ID: 32841926
    [Abstract] [Full Text] [Related]

  • 32. Performance of HPV Genotyping Combined with p16/Ki-67 in Detection of Cervical Precancer and Cancer Among HPV-Positive Chinese Women.
    Jiang MY, Wu Z, Li T, Yu L, Zhang SK, Zhang X, Qu P, Sun P, Xi MR, Liu X, Liao G, Sun L, Zhang Y, Chen W, Qiao YL.
    Cancer Prev Res (Phila); 2020 Feb 01; 13(2):163-172. PubMed ID: 31871224
    [Abstract] [Full Text] [Related]

  • 33. p16/ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology: results from the European equivocal or mildly abnormal Papanicolaou cytology study.
    Schmidt D, Bergeron C, Denton KJ, Ridder R, European CINtec Cytology Study Group.
    Cancer Cytopathol; 2011 Jun 25; 119(3):158-66. PubMed ID: 21442767
    [Abstract] [Full Text] [Related]

  • 34. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
    Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K.
    Cancer; 2006 Mar 01; 106(5):1054-64. PubMed ID: 16421920
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of p16(INK4a)/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with low-grade squamous intraepithelial lesion.
    Waldstrøm M, Christensen RK, Ørnskov D.
    Cancer Cytopathol; 2013 Mar 01; 121(3):136-45. PubMed ID: 22987560
    [Abstract] [Full Text] [Related]

  • 36. [Diagnostic value of p16/mcm2 dual staining in cervical intraepithelial neoplasia and its association with high-risk HPV infection].
    Wang HR, Liao GD, Jiang Y, Li YC, Qiao YL, Chen W.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep 10; 38(9):1241-1245. PubMed ID: 28910940
    [Abstract] [Full Text] [Related]

  • 37. Human papillomavirus viral load in predicting high-grade CIN in women with cervical smears showing only atypical squamous cells or low-grade squamous intraepithelial lesion.
    Santos AL, Derchain SF, Martins MR, Sarian LO, Martinez EZ, Syrjänen KJ.
    Sao Paulo Med J; 2003 Nov 06; 121(6):238-43. PubMed ID: 14989139
    [Abstract] [Full Text] [Related]

  • 38. The APTIMA HPV assay versus the Hybrid Capture 2 test in triage of women with ASC-US or LSIL cervical cytology: a meta-analysis of the diagnostic accuracy.
    Arbyn M, Roelens J, Cuschieri K, Cuzick J, Szarewski A, Ratnam S, Reuschenbach M, Belinson S, Belinson JL, Monsonego J.
    Int J Cancer; 2013 Jan 01; 132(1):101-8. PubMed ID: 22610699
    [Abstract] [Full Text] [Related]

  • 39. Role of Cervical Cancer Biomarkers p16 and Ki67 in Abnormal Cervical Cytological Smear.
    Gothwal M, Nalwa A, Singh P, Yadav G, Bhati M, Samriya N.
    J Obstet Gynaecol India; 2021 Feb 01; 71(1):72-77. PubMed ID: 33814802
    [Abstract] [Full Text] [Related]

  • 40. Improved abnormal Pap smear triage using cervical cancer biomarkers.
    Killeen JL, Dye T, Grace C, Hiraoka M.
    J Low Genit Tract Dis; 2014 Jan 01; 18(1):1-7. PubMed ID: 23760145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.